SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-001624
Filing Date
2024-02-23
Accepted
2024-02-23 16:30:20
Documents
20
Period of Report
2024-02-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K agrx-20240222x8k.htm   iXBRL 8-K 46876
2 EX-4.1 agrx-20240222xex4d1.htm EX-4.1 133029
3 EX-4.2 agrx-20240222xex4d2.htm EX-4.2 131830
4 EX-4.3 agrx-20240222xex4d3.htm EX-4.3 162111
5 EX-10.1 agrx-20240222xex10d1.htm EX-10.1 62504
6 EX-99.1 agrx-20240222xex99d1.htm EX-99.1 20463
  Complete submission text file 0001558370-24-001624.txt   803862

Data Files

Seq Description Document Type Size
7 EX-101.SCH agrx-20240222.xsd EX-101.SCH 3435
8 EX-101.LAB agrx-20240222_lab.xml EX-101.LAB 18738
9 EX-101.PRE agrx-20240222_pre.xml EX-101.PRE 12862
21 EXTRACTED XBRL INSTANCE DOCUMENT agrx-20240222x8k_htm.xml XML 4858
Mailing Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635
Business Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635 609-683-1880
AGILE THERAPEUTICS INC (Filer) CIK: 0001261249 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36464 | Film No.: 24671693
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)